Clinical Guides
Hyperthyroidism: Cause, Control and Definitive Care
Hyperthyroidism is excess thyroid hormone production that must be distinguished from destructive thyrotoxicosis before treatment, pregnancy counselling or definitive therapy.
MedNext Academy | 12 min read
Hyperthyroidism: Cause, Control and Definitive Care
Hyperthyroidism is excess thyroid hormone production that must be distinguished from destructive thyrotoxicosis before treatment, pregnancy counselling or definitive therapy.
Summary
Hyperthyroidism is thyrotoxicosis caused by increased thyroid-hormone synthesis, most often Graves’ disease, toxic multinodular goitre or a toxic adenoma. Thyrotoxicosis also occurs without hyperthyroidism, notably in thyroiditis or exogenous hormone exposure; antithyroid drugs do not correct hormone release from destructive thyroiditis. Symptoms include palpitations, tremor, heat intolerance, weight loss, anxiety, diarrhoea and menstrual change, but older adults may present with atrial fibrillation, heart failure, weight loss or apathy.
Biochemistry usually shows suppressed TSH with raised free T4 and/or free T3. Cause matters: TRAbs support Graves’ disease, while technetium uptake scanning helps when TRAbs are negative or uncertainty remains. Graves’ orbitopathy, diffuse goitre and pretibial myxoedema are clinical clues, not mandatory findings.
Treatment combines symptom control, cause-specific therapy and prevention of complications. Antithyroid drugs, radioactive iodine and surgery have different timelines, fertility implications and adverse effects. A beta-blocker may improve adrenergic symptoms but never substitutes for diagnosis. current guidelines guidance is UK evidence, not an Indian prescribing law; this quarantined guide requires local endocrine review. [current guidelines, 1.6.1-1.6.8]
Interpret results after checking assay method, biotin exposure and acute illness. Overtreatment can create hypothyroidism, while undertreatment leaves arrhythmia and bone risk. Record the aetiology explicitly because it determines whether synthesis-blocking drugs are biologically appropriate.
How Common Is It?
Hyperthyroidism is less common than hypothyroidism but clinically important because untreated disease can cause atrial fibrillation, osteoporosis, muscle wasting, heart failure and thyroid storm. Frequency depends on iodine intake, age, sex, autoimmune risk and diagnostic testing patterns. Graves’ disease is the commonest cause in iodine-sufficient populations, whereas toxic nodular disease becomes more prominent with age and in iodine-deficient settings. Exact Indian prevalence varies between surveys and regions; a single estimate should not be presented as a nationwide current rate.
Many people have symptoms for months before testing, and some are detected through new atrial fibrillation, weight loss or an incidental low TSH. Subclinical hyperthyroidism has low TSH with normal free hormones and is biologically and clinically distinct from overt disease. Current guidelines advises specialist advice for adults with TSH below 0.1 mIU/L on two readings at least three months apart plus symptoms or evidence of thyroid disease; this is a defined UK recommendation, not a diagnostic cut-off for every patient.
The practical epidemiological point is targeted suspicion: test when a compatible syndrome, autoimmune disease, or new atrial fibrillation is present. Do not screen or diagnose from anxiety, tremor or weight change alone. [current guidelines, 1.2.1-1.2.2 and 1.8.1]
Population burden should never be used to minimise an individual presentation. New arrhythmia, frailty, pregnancy and orbitopathy make the same biochemical result more consequential and alter the speed and setting of treatment.
Risk Factors
Ask about personal or family autoimmune thyroid disease, type 1 diabetes, vitiligo, coeliac disease, smoking, recent pregnancy, iodine or amiodarone exposure, prior neck radiation and previous thyroid nodules. Smoking worsens Graves’ orbitopathy risk and is a modifiable counselling priority. Recent iodinated contrast, amiodarone and supplements containing iodine can precipitate or modify thyrotoxicosis. Biotin can interfere with some immunoassays, so document use before interpreting discordant results.
Toxic nodular disease is more likely with age, multinodular goitre or longstanding iodine deficiency. Thyroiditis may follow pregnancy, viral illness, medicines or immune checkpoint therapy. Exogenous thyroid hormone should be considered with weight-loss products or inappropriate replacement. A patient’s symptoms should also trigger cardiac and bone risk assessment, especially in older people, people with coronary disease, atrial fibrillation, osteoporosis or frailty.
Pregnancy, planned conception and breastfeeding are management-changing contexts. Radioactive iodine is unsuitable in pregnancy, and antithyroid-drug choice and monitoring require specialist advice. In India, product availability, isotope access and endocrine surgery capacity vary, so document the actual service route rather than assuming a definitive-treatment option is nearby. [current guidelines, 1.6.15-1.6.17; ATA Hyperthyroidism Guideline overview]
Test autoimmune and nodular risk in parallel with severity. A previous iodine load may also make an uptake scan less informative, so timing and specialist interpretation matter rather than ordering every test simultaneously.
Diagnosis
History
Ask about weight change, heat intolerance, sweating, tremor, palpitations, dyspnoea, diarrhoea, proximal weakness, mood change, menstrual or fertility effects and eye symptoms. Establish onset, pregnancy status, medicines, supplements, iodine exposure, infection and past thyroid disease. Screen for chest pain, syncope, severe vomiting, agitation or confusion because these suggest cardiac decompensation or thyroid storm.
Examination
Record pulse, rhythm, blood pressure, temperature, weight and hydration. Examine hands for tremor, skin, proximal strength, reflexes, goitre, bruit, nodules and cervical compression. Look for lid lag, proptosis, diplopia, impaired colour vision and corneal exposure. Assess for atrial fibrillation, heart failure and delirium.
Investigations
Measure TSH first, with FT4 and FT3 when TSH is low or suspicion is strong. TRAbs distinguish Graves’ disease; if negative or cause remains uncertain, consider technetium scan. Current guidelines recommends ultrasound only with palpable nodule in adult thyrotoxicosis, avoiding incidental imaging. Obtain FBC and liver tests before antithyroid drugs, ECG for palpitations or arrhythmia, pregnancy test where relevant, and targeted calcium or bone assessment. [current guidelines, 1.6.1-1.6.2 and 1.7.9-1.7.10]
FT3-predominant disease can occur, so a low TSH with normal FT4 does not always end evaluation. Interpret results against pregnancy-specific and laboratory reference ranges where relevant.
Differential Diagnosis
First distinguish hyperthyroidism from thyrotoxicosis without increased synthesis. Graves’ disease, toxic multinodular goitre and toxic adenoma usually require antithyroid, radioactive iodine or surgical planning. Subacute, painless or postpartum thyroiditis releases preformed hormone and is usually managed supportively with symptom control; antithyroid drugs are ineffective. Factitious hormone, struma ovarii and amiodarone-associated disease need specific specialist assessment.
Non-thyroid causes of palpitations and weight loss include panic disorder, stimulant use, anaemia, infection, diabetes, malignancy and menopause. A low TSH may be altered by severe illness, glucocorticoids, dopamine, assay interference or central disease. Conversely, a clinically unwell person with fever and tachycardia may have sepsis rather than thyroid storm.
For eye symptoms, differentiate Graves’ orbitopathy from orbital infection, tumour, myasthenia or vascular disease. Pain, reduced vision, colour desaturation or corneal exposure are sight-threatening signs. A thyroid nodule with voice change, dysphagia, rapid growth or compression needs structural assessment and cancer pathway consideration rather than reflex radioiodine. [current guidelines, 1.6.1-1.6.2; ATA guideline overview]
Central causes of abnormal TSH are uncommon but should be considered when the biochemical pattern is discordant. Do not diagnose thyroiditis solely because pain is absent; antibody, scan and clinical context guide the distinction.
Management
Treat instability first. Thyroid storm is a clinical emergency with systemic decompensation, fever, marked tachycardia, heart failure, gastrointestinal symptoms or central nervous system disturbance; urgent ICU-capable endocrine care is required. Do not wait for every confirmatory result if storm is credible. For stable symptomatic thyrotoxicosis, beta-blockade can reduce tremor and palpitations when not contraindicated, while cause-directed treatment is arranged.
Current guidelines advises considering antithyroid drugs plus supportive treatment for adults with hyperthyroidism awaiting specialist assessment. Graves’ disease decisions should compare a course of antithyroid drugs, radioactive iodine and thyroidectomy, including relapse probability, orbitopathy, fertility plans, goitre size and patient preference. Toxic multinodular goitre commonly needs definitive treatment; Current guidelines offers radioactive iodine first line unless unsuitable.
Smoking cessation and coordinated eye care are essential for Graves’ orbitopathy. After radioiodine or surgery, lifelong hypothyroidism monitoring and replacement may be needed. International guideline pathways support decisions but must be adapted to Indian laboratory, isotope and surgical access. [current guidelines, 1.6.5-1.6.17]
Before definitive therapy, explain the likely need for replacement after radioiodine or thyroidectomy. Ensure follow-up is feasible, particularly when distance from endocrine services makes missed testing likely.
Prescribing Information
Carbimazole/methimazole and propylthiouracil have serious but uncommon adverse effects. Before starting, obtain baseline FBC and liver tests and counsel the patient to stop the drug and obtain urgent assessment for fever, sore throat, mouth ulcers, jaundice, dark urine, pruritus or abdominal pain because agranulocytosis or hepatotoxicity is possible. current guidelines does not recommend routine serial FBC or liver-function monitoring without symptoms; thyroid hormone monitoring, however, is regular.
Current guidelines suggests TSH, FT4 and FT3 every six weeks until TSH normalises, then TSH every three months while antithyroid drugs continue. Do not titrate from TSH alone early in therapy, when it may remain suppressed. Propylthiouracil and carbimazole have different pregnancy and hepatotoxicity considerations; selection requires current obstetric/endocrine guidance. Radioactive iodine is contraindicated in pregnancy and requires radiation-safety counselling.
Avoid unregulated thyroid supplements and do not use antithyroid drugs for thyroiditis. Beta-blockers require review for asthma, bradycardia, heart block and decompensated heart failure. Indian formulations and local protocols differ; verify the current CDSCO label, formulary and endocrinology plan before prescribing. [current guidelines, 1.7.9-1.7.10; current guidelines, 1.6.15-1.6.17]
Antithyroid doses and block-and-replace strategies are specialist decisions. Drug interactions, liver disease and previous adverse reactions should be documented before dispensing, rather than inferred from a medication list.
When to Refer
Refer immediately for suspected thyroid storm, atrial fibrillation with instability, acute heart failure, severe orbitopathy, vision change, delirium, severe vomiting or fever with marked tachycardia. Urgent endocrine and ophthalmology input is needed for diplopia, reduced visual acuity, colour-vision loss, corneal exposure or compressive optic neuropathy.
Refer routinely but promptly for confirmed overt hyperthyroidism, uncertain aetiology, nodular goitre, pregnancy, planned conception, childhood disease, recurrent disease, drug adverse effects, arrhythmia, osteoporosis or consideration of radioactive iodine or surgery. A large goitre with stridor, dysphagia, progressive hoarseness or rapid growth needs urgent surgical/ENT assessment.
Indian referral should identify whether the destination can provide TRAbs, isotope imaging, radioiodine, eye care, experienced thyroid surgery and post-treatment monitoring. NMC education supports recognition and referral, not independent radioiodine or antithyroid prescribing by an uncredentialed learner. [current guidelines, thyrotoxicosis and thyroid enlargement recommendations; NMC CBME 2024, PY8.3]
Referral letters should include exact hormone values and dates, pregnancy status, ECG findings, eye symptoms, medicines and baseline blood tests. This prevents repeated visits and unsafe delay before definitive planning.
Red Flags
Fever, severe tachycardia, agitation, confusion, coma, vomiting, diarrhoea, jaundice, atrial fibrillation, pulmonary oedema or shock in a thyrotoxic person are red flags for thyroid storm or another life-threatening illness. Treat this as emergency medicine, not a delayed outpatient endocrine result. Sepsis, pulmonary embolism, ketoacidosis and drug toxicity can mimic or precipitate decompensation.
Eye red flags are reduced visual acuity, impaired colour vision, visual-field loss, corneal ulceration, inability to close the lids, severe pain or rapidly progressive proptosis. Compression red flags include stridor, dysphagia, venous obstruction, hoarseness and a rapidly enlarging neck mass.
For antithyroid drugs, fever, sore throat, mouth ulcers, jaundice, itching, dark urine or severe abdominal pain require immediate drug-safety action and blood testing. Do not ask a patient to keep taking medication until a routine appointment. Pregnancy with uncontrolled symptoms, severe hyperemesis, or uncertain medicine exposure warrants urgent specialist advice. [current guidelines, 1.6.5-1.6.8 and 1.7.10]
Infection, surgery, trauma and abrupt antithyroid-drug cessation can precipitate storm. Ask about these triggers and take blood cultures or other acute investigations when infection is plausible.
Indian Clinical Context
India has variable access to sensitive thyroid assays, TRAbs, technetium uptake scans, radioiodine isolation facilities, orbitopathy services and high-volume thyroid surgeons. The correct first response is not indiscriminate scanning: obtain quality thyroid function tests, assess instability and arrange a named referral. A normal ultrasound does not establish the cause of biochemical thyrotoxicosis.
Iodine nutrition, self-medication and unregulated supplements can complicate interpretation. State and institutional systems differ in availability of carbimazole, propylthiouracil, beta-blockers and radioactive iodine. WHO or current guidelines drug and fertility advice must be checked against Indian labels and current specialist protocol, especially in pregnancy and breastfeeding.
Provide written safety advice in a language the patient understands, including drug adverse effects and eye/emergency symptoms. These international sources are evidence supports rather than Indian jurisdictional mandates; the Indian NMC curriculum defines learner scope, while clinical services set prescribing and referral rules. [NMC CBME 2024, PY8.3; current guidelines, scope and recommendations]
Cost and transport should influence referral design, not diagnostic standards. Where isotope treatment is inaccessible, early endocrine discussion can select a sustainable medical or surgical plan and monitoring schedule.
NMC Competency Mapping
NMC CBME Curriculum 2024 explicitly maps thyroid physiology and altered thyroid secretion to PY8.3 at Know How level. For clinical learning, the student should connect thyroid-function tests with symptoms and autonomic physiology, not merely memorise a hormone pattern. A case of Graves’ disease tests endocrine, cardiovascular, ophthalmic, pharmacology and communication skills.
Learners should take a focused history, recognise tremor, goitre, eye disease and atrial fibrillation, request TSH/FT4/FT3 with supervision, distinguish Graves’ disease from thyroiditis conceptually, and identify storm and drug-toxicity danger signs. They should explain the choices of antithyroid drugs, radioiodine and surgery without promising a particular option.
Students must not independently prescribe antithyroid medication, manage storm, arrange radioisotope treatment or reassure a patient with visual loss. Assessment may use a pregnancy counselling vignette, a new atrial fibrillation presentation and a sore-throat-on-carbimazole safety call. [NMC CBME 2024, PY8.3; current guidelines, 1.6 and 1.7]
PY8.3 supports thyroid physiology understanding, but patient management requires supervised integration of other domains. The educational aim is a safe explanation of uncertainty and escalation, not confidence beyond competence.
Key Exam Pearls for NEET PG
Suppressed TSH with high FT4/FT3 indicates overt thyrotoxicosis; establish whether there is increased synthesis. TRAbs support Graves’ disease. Thyroiditis is thyrotoxicosis without hyperthyroidism, so antithyroid drugs are not useful. Graves’ disease can produce diffuse goitre, bruit, orbitopathy and pretibial myxoedema.
New atrial fibrillation is a thyroid-testing indication. Thyroid storm is clinical: fever, marked tachycardia, CNS disturbance and cardiovascular or gastrointestinal decompensation demand emergency treatment. Do not wait for a scan. Fever or sore throat during antithyroid therapy suggests agranulocytosis until excluded.
Radioiodine is unsuitable in pregnancy and can worsen active orbitopathy; surgery gives rapid control for selected patients. Use Indian context honestly: NMC PY8.3 anchors physiology learning, but availability of TRAbs, isotope studies and definitive therapy is local. [current guidelines, 1.2.2, 1.6 and 1.7; NMC CBME 2024, PY8.3]
For viva answers, contrast Graves disease with toxic nodular disease and thyroiditis, then state how TRAbs or uptake testing changes management. This demonstrates mechanism rather than isolated fact recall.
Frequently Asked Questions
Is every person with low TSH treated with an antithyroid medicine?
No. Low TSH requires confirmation and clinical interpretation. Overt hormone excess, subclinical disease, thyroiditis, assay interference, medicines and non-thyroid illness differ. Antithyroid drugs suppress new hormone synthesis and are ineffective for destructive thyroiditis. A clinician must establish the cause, severity, pregnancy status and cardiac risk before treatment. Keep a written record of the test result, medicine or treatment date, and planned review. If symptoms worsen, if a new medicine is started, or if follow-up testing cannot be obtained as arranged, contact the responsible clinical service rather than changing treatment independently. Laboratory reports should be interpreted using the stated reference interval, sampling circumstances and the full clinical picture. For example, suppressed TSH can persist after hormone concentrations improve, and a normal pulse after beta-blockade does not prove hormone synthesis has resolved. This is why a formal review plan includes both symptoms and repeat thyroid function tests.
What symptoms require urgent action while taking carbimazole or methimazole?
Stop the medicine and seek urgent medical assessment for fever, sore throat, mouth ulcers, jaundice, dark urine, severe itching or abdominal pain. These may signal agranulocytosis or liver injury. Do not restart the medicine without the prescriber’s advice. Routine blood monitoring does not replace immediate symptom-triggered assessment. Keep a written record of the test result, medicine or treatment date, and planned review. If symptoms worsen, if a new medicine is started, or if follow-up testing cannot be obtained as arranged, contact the responsible clinical service rather than changing treatment independently.
Can radioactive iodine be used during pregnancy?
No. Radioactive iodine is unsuitable in pregnancy and requires fertility, radiation-safety and eye-disease counselling. Pregnancy with hyperthyroidism needs urgent endocrine-obstetric planning because antithyroid-drug choice, dose and fetal monitoring are individualized. Do not stop treatment or take isotope therapy on the basis of a generic online plan. Keep a written record of the test result, medicine or treatment date, and planned review. If symptoms worsen, if a new medicine is started, or if follow-up testing cannot be obtained as arranged, contact the responsible clinical service rather than changing treatment independently.
Does successful treatment mean thyroid tests will never be needed again?
No. Antithyroid drugs require regular hormone monitoring, and radioactive iodine or surgery often leads to lifelong hypothyroidism needing replacement and testing. Recurrence can occur after a medication course. Monitoring frequency depends on the treatment, laboratory results, symptoms and local specialist plan. Keep a written record of the test result, medicine or treatment date, and planned review. If symptoms worsen, if a new medicine is started, or if follow-up testing cannot be obtained as arranged, contact the responsible clinical service rather than changing treatment independently.
Inside MedNext for this topic
- 411 MedNext-authored chapters
- 80,000+ MCQ bank
- 15 study modes
- a growing library of visual revision sheets
Study modes
- Notes
- MCQ
- Audio
- Video
- Visual
- 3D Anatomy
- Trace
- Flashcards
- Mnemonics
- Image Bank
- Clinical
- Microscopy
- Audio QBank
- Cadaver
- Book Match
Continue reading
Clinical GuidesAll Clinical Guides
Browse all clinical management guides for Indian medical practice.
Test your knowledge
Attempt structured MCQs on this topic to consolidate your understanding and connect the guide to exam-focused practice.
Try MCQs on this topic